These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19252770)

  • 1. SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD).
    Iorio R; Capone F; Iannaccone E; Willison HJ; Modoni A; Tonali PA; Silvestri G
    J Neurol; 2009 Jul; 256(7):1177-9. PubMed ID: 19252770
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies against disialosyl and terminal NeuNAc(alpha2-3)Gal ganglioside epitopes in acute relapsing sensory ataxic neuropathy.
    Rojas-Garcia R; Gallardo E; Povedano M; de Luna N; Bruna J; Juarez C; Diaz-Manera J; Martinez-Matos JA; Illa I
    J Neurol; 2008 May; 255(5):764-6. PubMed ID: 18344054
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensory Guillain-Barré syndrome after Campylobacter jejuni infection.
    Rajabally YA; Kass-Hout T; Wilson P; Damian MS
    Eur J Neurol; 2007 Mar; 14(3):e11-2. PubMed ID: 17355531
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic sensory ataxic neuropathy associated with IgM antibody against b-series gangliosides including GD1b].
    Susuki K; Koga M; Yuki N; Johkura K; Kuroiwa Y
    Rinsho Shinkeigaku; 1999 Sep; 39(9):967-70. PubMed ID: 10614164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CANOMAD and other chronic ataxic neuropathies with disialosyl antibodies (CANDA).
    Garcia-Santibanez R; Zaidman CM; Sommerville RB; Lopate G; Weihl CC; Pestronk A; Bucelli RC
    J Neurol; 2018 Jun; 265(6):1402-1409. PubMed ID: 29633012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Guillain-Barré syndrome complicated with severe autonomic failure and presented elevated anti-GD1b and anti-GQ1b antibody].
    Inoue K; Kohriyama T; Ikeda J; Maruyama H; Nakamura S
    Rinsho Shinkeigaku; 2002 Jan; 42(1):13-7. PubMed ID: 12355845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycranial neuropathy and sensory ataxia with IgG anti-GD1a antibody as a variant of Guillain-Barré syndrome.
    Kim SY; Kim JK; Suh CK
    J Clin Neurosci; 2013 Mar; 20(3):473-5. PubMed ID: 23164827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome.
    Lo YL
    Lancet Neurol; 2008 Dec; 7(12):1082-3; author reply 1083-5. PubMed ID: 19007732
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism.
    Yuki N; Uncini A
    Muscle Nerve; 2014 May; 49(5):629-35. PubMed ID: 24477718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.
    Yuki N; Susuki K; Hirata K
    Neurology; 2000 May; 54(9):1851-3. PubMed ID: 10802797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibodies in Guillain-Barré Syndrome].
    Uchibori A; Chiba A
    Brain Nerve; 2015 Nov; 67(11):1347-57. PubMed ID: 26560950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification and characterization of a monoclonal IgM reacting with disialylated gangliosides recognizing the CANOMAD syndrome].
    Boussaïd I; Bouhour F; Vial C; Caudie C
    Ann Biol Clin (Paris); 2011; 69(4):476-80. PubMed ID: 21896416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete recovery of an aged patient with Guillain-Barré syndrome associated with multiple IgM anti-ganglioside antibodies.
    Furiya Y; Hirano M; Kusunoki S; Ueda M; Sugie K; Nishiwaki T; Ueno S
    Muscle Nerve; 2008 Dec; 38(6):1630-3. PubMed ID: 19016534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
    Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
    Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies.
    Rojas-García R; Querol L; Gallardo E; De Luna Salva N; Juarez C; Garces M; Fages E; Casasnovas C; Illa I
    J Peripher Nerv Syst; 2012 Jun; 17(2):158-68. PubMed ID: 22734901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome.
    Willison HJ; O'Hanlon G; Paterson G; O'Leary CP; Veitch J; Wilson G; Roberts M; Tang T; Vincent A
    J Infect Dis; 1997 Dec; 176 Suppl 2():S144-9. PubMed ID: 9396699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome.
    Kountouras J; Deretzi G; Grigoriadis N; Zavos C; Boziki M; Gavalas E; Katsinelos P; Tzilves D; Giouleme O; Lazaraki G
    Lancet Neurol; 2008 Dec; 7(12):1080-1; author reply 1083-5. PubMed ID: 19007730
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoglobulin therapy for idiopathic chronic sensory ataxic neuropathy.
    Takeuchi H; Misu K; Hattori N; Nagamatsu M; Sobue G
    Neurology; 2000 Feb; 54(4):1008-10. PubMed ID: 10691009
    [No Abstract]   [Full Text] [Related]  

  • 20. Miller-Fisher syndrome with rapid recovery.
    Hammers A; Hardie RJ
    Lancet; 1994 May; 343(8908):1290. PubMed ID: 7910293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.